Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms

Nosocomial infection, in particular pneumonia, is an important risk factor for hospital mortality and morbidity. Acinetobacter baumanii is a common multi-resistant microorganism responsible of Ventilator Associated Pneumonia (VAP). Currently Colistin is a rescue therapy for this pathogen. The purpos...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Bonito, Marianna, Caiazzo, Simona, Iannazzone, Marta, Miccichè, Viviana, De Marco, Giuseppe, De Robertis, Edoardo, Tufano, Rosalba, Piazza, Ornella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università di Salerno 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728786/
https://www.ncbi.nlm.nih.gov/pubmed/23905048
Descripción
Sumario:Nosocomial infection, in particular pneumonia, is an important risk factor for hospital mortality and morbidity. Acinetobacter baumanii is a common multi-resistant microorganism responsible of Ventilator Associated Pneumonia (VAP). Currently Colistin is a rescue therapy for this pathogen. The purpose of this retrospective study is to compare the outcome of VAP caused by Acinetobacter baumanii and VAP from other microorganisms in critical patients. Comorbidity, prognostic scores, mortality and eradication frequency did not turn out significantly different between the two study groups. Colistin safety was tested.

Ejemplares similares